197 related articles for article (PubMed ID: 36087225)
21. The role of molecular techniques in the clinical management of leukemia. Lessons from the Philadelphia chromosome.
Westbrook CA
Cancer; 1992 Sep; 70(6 Suppl):1695-700. PubMed ID: 1516023
[TBL] [Abstract][Full Text] [Related]
22. [Detection on BCR-ABL fusion gene in Ph1 chromosome positive leukemia by "nested" retrotranscriptase/polymerase chain reaction].
Huang W; Cao Q; Lu Y
Zhonghua Yi Xue Za Zhi; 1994 Nov; 74(11):662-5, 708. PubMed ID: 7866899
[TBL] [Abstract][Full Text] [Related]
23. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan.
Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF
Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959
[TBL] [Abstract][Full Text] [Related]
24. Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript.
Selleri L; von Lindern M; Hermans A; Meijer D; Torelli G; Grosveld G
Blood; 1990 Mar; 75(5):1146-53. PubMed ID: 2407300
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
[TBL] [Abstract][Full Text] [Related]
26. Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia.
Ni H; Nitta M; Komatsu H; Kojima S; Suzuki S; Harada S; Tsuboi K; Banno S; Wakita A; Yazaki M; Ren L; Kato T; Ueda R
Cancer Lett; 1998 Feb; 124(2):173-80. PubMed ID: 9500207
[TBL] [Abstract][Full Text] [Related]
27. p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia.
Lemes A; Gómez Casares MT; de la Iglesia S; Matutes E; Molero MT
Cancer Genet Cytogenet; 1999 Aug; 113(1):100-2. PubMed ID: 10459357
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine kinase inhibitors for the treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Piccaluga PP; Paolini S; Martinelli G
Cancer; 2007 Sep; 110(6):1178-86. PubMed ID: 17701954
[TBL] [Abstract][Full Text] [Related]
29. p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.
van Rhee F; Hochhaus A; Lin F; Melo JV; Goldman JM; Cross NC
Blood; 1996 Jun; 87(12):5213-7. PubMed ID: 8652835
[TBL] [Abstract][Full Text] [Related]
30. Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors.
Redaelli S; Mologni L; Rostagno R; Piazza R; Magistroni V; Ceccon M; Viltadi M; Flynn D; Gambacorti-Passerini C
Am J Hematol; 2012 Nov; 87(11):E125-8. PubMed ID: 23044928
[TBL] [Abstract][Full Text] [Related]
31. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
Kolenova A; Maloney KW; Hunger SP
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
[TBL] [Abstract][Full Text] [Related]
32. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
[TBL] [Abstract][Full Text] [Related]
33. Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients.
Janssen JW; Fonatsch C; Ludwig WD; Rieder H; Maurer J; Bartram CR
Leukemia; 1992 May; 6(5):463-4. PubMed ID: 1593911
[TBL] [Abstract][Full Text] [Related]
34. Malignant transformation by abl and BCR/ABL.
Van Etten RA
Cancer Treat Res; 1992; 63():167-92. PubMed ID: 1363357
[No Abstract] [Full Text] [Related]
35. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
[TBL] [Abstract][Full Text] [Related]
36. Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report.
Ahmed IO; Ochogwu LO; Owojuyigbe TO; Akinola NO; Durosinmi MA
J Med Case Rep; 2021 Oct; 15(1):504. PubMed ID: 34625105
[TBL] [Abstract][Full Text] [Related]
37. A Ph+ acute myeloid leukaemia expressing both CML-type and ALL-type BCR/ABL mRNA transcripts.
Williams BG; Yin JL; Ma DD
Leuk Lymphoma; 1994 Jul; 14(3-4):341-6. PubMed ID: 7950925
[TBL] [Abstract][Full Text] [Related]
38. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.
Talpaz M; Shah NP; Kantarjian H; Donato N; Nicoll J; Paquette R; Cortes J; O'Brien S; Nicaise C; Bleickardt E; Blackwood-Chirchir MA; Iyer V; Chen TT; Huang F; Decillis AP; Sawyers CL
N Engl J Med; 2006 Jun; 354(24):2531-41. PubMed ID: 16775234
[TBL] [Abstract][Full Text] [Related]
39. Ponatinib in refractory Philadelphia chromosome-positive leukemias.
Cortes JE; Kantarjian H; Shah NP; Bixby D; Mauro MJ; Flinn I; O'Hare T; Hu S; Narasimhan NI; Rivera VM; Clackson T; Turner CD; Haluska FG; Druker BJ; Deininger MW; Talpaz M
N Engl J Med; 2012 Nov; 367(22):2075-88. PubMed ID: 23190221
[TBL] [Abstract][Full Text] [Related]
40. Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Hooberman AL; Carrino JJ; Leibowitz D; Rowley JD; Le Beau MM; Arlin ZA; Westbrook CA
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4259-63. PubMed ID: 2498881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
